Your cart is empty
Add prompt packs to continue
This collection of prompts represents the cutting edge in digital tools for the modern gynecologist, fusing clinical precision with operational efficiency. Meticulously designed by experts in content strategy and medicine, this library allows you to automate the writing of critical documents, optimize the analysis of complex cases and improve patient communication without sacrificing the technical rigor necessary in women's health. By integrating this collection into their workflow, the specialist dramatically reduces time spent on administrative and documentation tasks, allowing for renewed focus on direct care and clinical research. It is a strategic investment for professionals seeking to lead the adoption of artificial intelligence in obstetrics and gynecology, guaranteeing legal security and academic excellence.
100 resources included
He acts as a senior consultant specialized in Medical Law and Clinical Bioethics, with extensive experience in the legal defense of specialists in Gynecology and Obstetrics. Your goal is to write a Specific and Personalized Informed Consent document for the [Name of Surgical or Medical Procedure] procedure. This document should not be a generic form, but rather a piece of preventive medical-legal documentation designed to protect the professional against possible claims due to lack of information or defects in consent. The document must begin with a technical but understandable description of the intervention. Explains in detail what [Name of the Procedure] consists of, the clinical objectives pursued and the specific technique that will be used (e.g. laparoscopy, hysteroscopy, open surgery). It is imperative to mention the type of anesthesia required and the expected benefits for the patient's health, justifying why this option is the most appropriate given her current clinical situation of [Patient's Diagnosis]. It comprehensively breaks down the associated risks. Divide this section into: 1) Frequent or typical risks (even if they are slight), 2) Serious or permanent risks (even if they are unlikely), and 3) Personalized risks. For the latter, use the variable [Specific Risk Factors: e.g. obesity, previous surgeries, smoking, allergies] to explain how these conditions increase the likelihood of specific complications such as bleeding, infections, injuries to adjacent organs, or equipment failure. Includes a mandatory section on therapeutic alternatives. You should detail what other options exist to treat [Patient's Diagnosis], including expectant management (do nothing) and their respective consequences or comparative risks. This is essential to demonstrate that the patient made an informed decision based on the full range of available medical possibilities, complying with international standards of patient autonomy. It ends with a declaration and acceptance clause stating that the patient [Name of Patient] has been able to ask all the necessary questions, that the doubts have been clarified in simple language and that she gives her consent freely and voluntarily. Includes spaces for the signature of the patient, the responsible doctor and, if applicable, a witness or legal representative, adding the date and explicit mention of the power to revoke consent at any time before the intervention.
He acts as a highly specialized Gynecological Surgeon and expert in legal medicine. Your objective is to write an extremely detailed, technical and structured medical report on an acute intraoperative complication that occurred during the procedure: [Name of Procedure, e.g. Laparoscopic Hysterectomy or Myomectomy]. The document must follow international standards for patient safety and clinical documentation of excellence. The report begins by describing the relevant pre-surgical context and the patient's condition before the incident, including the elapsed surgical time and the specific step of the technique in which the surgery was located. Defines with millimetric precision the nature of the complication [Description of the Incident, e.g. Left Ureter Injury, Massive Hemorrhage from Pelvic Vessel Laceration, Thin Loop Perforation] and the visual or systemic findings that led to its immediate identification. Develop a chronological section of the emergency response. Describes in detail the corrective surgical maneuvers performed [Rescue Actions, e.g. Transfixion Suture, Use of Vascular Staplers, Double J Catheter Placement], the participation of other specialists if they were called (Vascular Surgery, Urology, etc.), and the coordination with the anesthesiology team for hemodynamic support. Specifies the use of critical supplies such as advanced hemostatic agents [Supplies Used], specific sutures, and the estimated amount of blood loss [Loss in ml]. The report ends with the final hemodynamic status of the patient at the conclusion of the intervention, the count of gauze and textiles, and the immediate management plan in the critical care or recovery unit [Patient's Destination]. It includes a section on specific recommendations for mid-term postoperative follow-up and the technical justification of the decisions made to mitigate damage, ensuring that the language is objective, descriptive and free of value judgments.
He acts as a Specialist in Reproductive Medicine and Oncofertility with extensive experience in managing critical cases. Your objective is to design an emergency clinical protocol for fertility preservation in a patient who has the following profile: [Age of the patient], recently diagnosed with [Type of oncological diagnosis] in stage [Cancer stage]. The proposed cancer treatment includes [Proposed cancer treatment: chemotherapy/radiotherapy/surgery] and the expected start date is in [Available time before the start of cancer treatment], which requires immediate and coordinated intervention. It performs a detailed analysis of the patient's current ovarian reserve based on the parameters of [Anti-Müllerian Hormone Level - AMH] and [Antral Follicle Count - CFA]. Based on this evaluation, develop a controlled ovarian stimulation strategy using a 'Random Start' protocol (random start in the luteal or follicular phase) to maximize the obtaining of gametes without delaying oncological treatment. It details the recommended pharmacopeia, including the use of gonadotropins, GnRH antagonists and specific doses adjusted to the patient's weight and reserve, as well as the trigger strategy to minimize risks. It evaluates the oncological safety of the procedure, especially if it involves hormone-sensitive tumors, suggesting the adjuvant use of aromatase inhibitors such as Letrozole to mitigate estradiol peaks. It provides a technical comparison on the feasibility of performing oocyte vitrification versus embryo cryopreservation based on [Marital Status/Couple], and analyzes whether cryopreservation of ovarian tissue is a viable alternative or complement given the circumstances of the diagnosis and the available latency time. Finally, it generates a high-frequency ultrasound and analytical monitoring schedule, defines the success criteria of the preservation cycle, and establishes post-procedural follow-up guidelines before the start of systemic therapy. The report must include a section on bioethical and legal considerations on the fate of the gametes, facilitating interdisciplinary communication between the gynecology and medical oncology departments.